Health Condition
Conditions
Interventions
Injection of [11C]MTP38
Sponsors
Tagai Kenji
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Healthy male subjects
Exclusion criteria
Exclusion criteria: 1.Subjects who do not have ability to make informed consent. 2. Subjects with any psychiatric disorder or subjects with severe physical complication. 3. Subjects who currently smokes. 4. Subjects with any organic brain disorder. 5. Subjects with metallic medical device in the body. 6. Subjects with tattoo. 7. Subjects with severe claustrophobia. 8. Subjects with a history of allergy to heparin and local anesthetics. 9. Subjects who are taking an anticoagulant. 10. Subjects who has participated in other study in recent 6 months. 11. Subjects who has participated in blood donation in recent 12 weeks. 12. Subjects who is considered to be inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics, and distribution volume or binding potentials of [11C]MTP38 in human brain | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between distribution volume of [11C]MTP38 and MRI data | — |
Contacts
Public ContactKenji Tagai
Institute for Quantum Medical Science, Quantum Medical Science Directorate, National Institutes for Quantum Science and Technology (QST)
Outcome results
None listed